Contract award · 7 Aug 2025

Measles, Mumps, Rubella and Varicella (MMRV) vaccine (2025)

UK Health Security Agency awarded “Measles, Mumps, Rubella…” to GlaxoSmithKline UK Ltd - Vaccines, Merck Sharpe and Dohme (UK) Limited for £1.

Medical equipment & pharmaceuticalsLondon

Open competition

Open procedure: the contract was advertised and any supplier could submit a bid.

Key facts

Value
£1
Procedure
Open procedure (above threshold)
Sector
Medical equipment & pharmaceuticals · Vaccines (CPV 33651600)
Region
London
Timeline
  1. Contract date7 Aug 2025
  2. Published29 Aug 2025Published 22 days after the contract date

Description

Contracts for the supply of vaccine to protect against measles, mumps, rubella and varicella, to be used as part of the national immunisation programme. Deliveries will be required over a period of 2 years, with an option to extend for up to an additional 24 months. The awarding of lots is not appropriate for this procurement. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier.

About the suppliers

More from UK Health Security Agency

All contracts

More won by GlaxoSmithKline UK Ltd - Vaccines

All contracts

Recent medical equipment & pharmaceuticals contracts

Sector overview